Oramed Pharmaceuticals Inc (NASDAQ:ORMP)

Data as of Jan 26
 +0.07 / +1.44%
Today’s Change
Today|||52-Week Range

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year




Revenue and IncomeNet Revenues0.
Operating ExpensesGross Income-28.3K-14.7K-5.4K-6.0K
Total Operating Expenses2.4M2.9M4.3M6.3M
Non-Operating ExpensesOperating Income-2.4M-2.9M-4.3M-6.3M
Extraordinary Credit0.000.0044.7K--
Extraordinary Charge-197.4K-184.3K----
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-1.6M-3.3M-4.4M-5.7M
Income Taxes-24.0K-90.2K-205.1K-4.0K
Net Income-1.6M-3.3M-4.2M-5.7M
Shares To Calculate EPSShares To Calculate EPS5.4M5.9M7.2M9.2M
Shares To Calculate EPS Diluted5.4M5.9M7.2M9.2M
Earnings Per ShareEPS-$0.24-$0.60-$0.59-$0.62
EPS Diluted----------

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.